Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Telenav to Present at Canaccord Genuity Conference
-
Transition Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Adept Technology to Present at the Canaccord Genuity 35th Annual Growth Conference
-
ImmunoGen, Inc. Announces Canaccord Genuity Growth Conference Webcast
-
Datalink Corporation to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Zynerba Pharmaceuticals Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Zynerba Pharmaceuticals Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Proto Labs, Inc. to Present at the 35th Annual Canaccord Genuity Growth Conference
-
GlycoMimetics to Present at the Canaccord Genuity Growth Conference
-
Canaccord Genuity Upgrades Pengrowth Energy Trust (PGH) to Buy
-
Notable Analyst Rating Changes 8/10: (NLSN) (TTMI) (OKS) Upgraded; (JD) (WLK) (GPS) Downgraded
-
Canaccord Genuity Cuts Price Target on OraSure Technologies (OSUR) Following 2Q Results and Guidance
-
Medifast, Inc. to Participate in the Canaccord Genuity 35th Annual Growth Conference
-
Imprivata to Present at the Canaccord Genuity Growth Conference
-
Sierra Wireless to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Endologix to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Carmanah Reports Second Quarter 2015 Results
-
Cancer Genetics (CGIX) Enters Purchase Agreement to Acquire Response Genetics (RGDX)
-
Response Genetics Inc. Enters Into Asset Purchase Agreement With Cancer Genetics Inc.; Proposed Transaction to be Effectuated Through Voluntary Chapter 11; Business Uninterrupted
-
SCYNEXIS, Inc. to Present at 35th Canaccord Genuity Annual Growth Conference
-
Canaccord Genuity Downgrades TELUS Corporation (TU) to Hold
-
Canaccord Genuity Starts Vonage (VG) at Buy
-
Canaccord Genuity Starts ShoreTel (SHOR) at Buy
-
Canaccord Genuity Starts RingCentral (RNG) at Buy
-
Canaccord Genuity Starts 8x8 (EGHT) at Buy
-
Canaccord Genuity Upgrades Ritchie Bros (RBA) to Buy
-
GTT to Present at Pacific Crest, Canaccord Genuity and Oppenheimer Investor Conferences
-
Aptose Biosciences to Present at Canaccord Genuity 35th Annual Growth Conference
-
Vanda Pharmaceuticals to Present at the Canaccord Genuity Annual Growth Conference
-
ePlus to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Perk.com Inc. to Present at Canaccord Genuity 35th Annual Growth Conference
-
Perceptron Schedules Fourth-Quarter and Full-Year 2015 Conference Call/Webcast for August 27, 2015; Management to Present at the Canaccord Genuity Growth Conference on August 12, 2015
-
3D Systems to Present at the Canaccord Genuity 35th Annual Growth Conference
-
3D Systems to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Itron to Present at the 35th Annual Canaccord Genuity Growth Conference
-
Castlight Health, Inc. to Present at Upcoming Investor Conferences
-
Canadian Utilities Limited Announces Closing of $125 Million Preferred Share Issue
-
Benefitfocus (BNFT) Prices 2M Common Stock Secondary at $6.75/Share
-
Benefitfocus Announces Pricing of Secondary Offering
-
Benefitfocus Announces Pricing of Secondary Offering
-
Xenon Pharmaceuticals to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Cepheid to Webcast Upcoming Financial Presentations
-
PowerSecure To Present At Upcoming Investor Conferences
-
Fate Therapeutics to Present at Upcoming Investor Conferences
-
Fate Therapeutics to Present at Upcoming Investor Conferences
-
Aduro Biotech to Present at the 35th Annual Canaccord Genuity Growth Conference
-
Aduro Biotech to Present at the 35th Annual Canaccord Genuity Growth Conference
-
Xylem Inc. to participate in the 2015 Canaccord Genuity 35th Annual Growth Conference
-
Notable Analyst Rating Changes 8/6: (S) (DDR) (SLF) Upgraded; (SHPG) (GMCR) (AVOL) Downgraded
-
WiLAN to Present at Canaccord Genuity 35th Annual Growth Conference

